TCM LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.78 INR | +2.48% |
|
+1.79% | +3.63% |
| 05-27 | TCM Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| 05-27 | TCM Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
| Sales 2022 | 35.54 2.97K 2.8K | Sales 2023 | 73.48 6.13K 5.79K | Capitalization | 248M 20.65B 19.51B |
|---|---|---|---|---|---|
| Net income 2022 | -33M -2.75B -2.6B | Net income 2023 | -40M -3.34B -3.15B | EV / Sales 2022 | 11,791,031 x |
| Net Debt 2022 | 254M 21.21B 20.04B | Net Debt 2023 | 13.18M 1.1B 1.04B | EV / Sales 2023 | 3,548,094 x |
| P/E ratio 2022 |
-5
x | P/E ratio 2023 |
-5.54
x | Employees | 37 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 41.53% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.48% | ||
| 1 week | +1.79% | ||
| Current month | +3.50% | ||
| 1 month | -14.66% | ||
| 3 months | -10.90% | ||
| 6 months | +6.04% | ||
| Current year | +3.63% |
1 week
46.00
49.90
1 month
44.2559.80
Current year
43.9366.97
1 year
34.9066.97
3 years
26.45113.75
5 years
26.45113.75
10 years
21.00113.75
| Managers | Title | Age | Since |
|---|---|---|---|
Joseph Varghese
CEO | Chief Executive Officer | 66 | 30/12/05 |
M.P. Mohanan
DFI | Director of Finance/CFO | 67 | 26/03/19 |
Gokul Shenoy
CMP | Compliance Officer | - | 30/11/18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
George Varghese
BRD | Director/Board Member | 62 | 18/01/07 |
Ramesh Babu
BRD | Director/Board Member | 62 | - |
Joseph Varghese
CEO | Chief Executive Officer | 66 | 30/12/05 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/06/24 | 48.78 | +2.48% | 8,768 |
| 24/06/24 | 47.6 | -1.08% | 4,339 |
| 21/06/24 | 48.12 | -1.80% | 4,368 |
| 20/06/24 | 49 | +1.49% | 10,578 |
| 19/06/24 | 48.28 | +0.75% | 6,384 |
Delayed Quote Bombay S.E., June 25, 2024 at 11:00 am
More quotes
TCM Limited is an India-based company engaged in the business of trading of solar panels and health care products, installation of solar panels and manufacturing of cattle feed. The Company operates through three segments: Trading, Manufacturing and Educational. Its Trading segment is engaged in trading in solar, healthcare and auto care products. It offers Fluorecare quantitative POCT platform, which is one step rapid test for various applications, including thyroid, fertility, cardiac marker, tumor marker, inflammation, torch, anemia, diabetes, bone metabolism and others. Its subsidiaries include iSpark Learning Solutions Private Limited, TCM Healthcare Private Limited, TCM Properties Private Limited and TCM Solar Private Limited.
Sector
Commodity Chemicals
Calendar
11/08/2024
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +3.63% | 4.27M | |
| +4.00% | 102B | |
| -11.26% | 59.57B | |
| +68.10% | 46.57B | |
| +11.66% | 36.46B | |
| +0.42% | 31.75B | |
| +4.59% | 19.34B | |
| +14.08% | 16.96B | |
| +7.06% | 13.37B | |
| -8.41% | 12.5B |
- Stock Market
- Equities
- TCMLMTD6 Stock
